Tailored Approaches to Improve Medication Adherence

Conditions:High Blood Pressure (Hypertension)
Therapuetic Areas:Cardiology / Vascular Diseases
Age Range:18 - Any
Start Date:April 2013
End Date:August 2018
Contact:Antoinette Schoenthaler, EdD

Use our guide to learn which trials are right for you!

The purpose of this study is to to culturally tailor a technology-based individualized
adherence intervention for Black and Latino patients with uncontrolled HTN or T2DM, who are
non-adherent to their medications, and determine its acceptability.

Using a randomized controlled trial design, this study will compare the efficacy of a
tailored adherence intervention (TAI) to a single patient education (PE) session, on
medication adherence among 40 high-risk Latino patients with uncontrolled hypertension (HTN)
who are non-adherent to their prescribed antihypertensive medications. Patients randomized to
the PE group will receive a single patient education session on HTN and medication management
by a trained research assistant (RA) at the baseline visit. Patients randomized to the TAI
group will complete a tailoring survey at the baseline visit to identify the most salient
adherence barriers to the individual, which will be used to create an individualized
adherence profile. Following completion of the tailoring survey, patients will collaborate
with the RA to identify the most suitable mix of intervention strategies for improving
medication adherence (i.e., reminder aids, motivational interviewing, case management) that
are matched to the barriers outlined on patients' individualized adherence profiles.

Inclusion Criteria:

- Have uncontrolled hypertension defined as BP>140/90 mmHg on at least two consecutive
visits in the past year (or BP>130/80 mmHg for those with diabetes or kidney disease)
and Framingham Risk Scores (FRS) >20% (or at least one CVD risk factor including
hyperlipidemia or diabetes);

- Have been prescribed at least one antihypertensive or oral anti-diabetic medication;

- Self-identify as Latino or African American/Black

- Be > 18 years of age

Exclusion Criteria:

- Refuse or are unable to provide informed consent;

- Currently participate in another hypertension study; or 2 diabetes study

- Have significant psychiatric comorbidity

- Plan to discontinue care at the clinic within the next 3 months

Vulnerable populations including adults unable to provide informed consent, pregnant women,
and prisoners will be excluded from this study.
We found this trial at
New York, New York 10001
Principal Investigator: Maria Pitaro, MD
Phone: 212-924-2510
New York, NY
Click here to add this to my saved trials